Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-22.31M
↑ 41% vs avg
Percentile
P43
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-37.86M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-22.31M | +73.6% |
| 2024 | $-84.59M | +31.2% |
| 2023 | $-123.00M | -148.3% |
| 2022 | $-49.54M | -1666.6% |
| 2021 | $3.16M | +114.6% |
| 2020 | $-21.59M | -461.2% |
| 2019 | $-3.85M | -223.4% |
| 2018 | $-1.19M | - |